quadrivalent subunit influenza vaccine

BIOLOGICAL2 trials

Sponsors

Ab&B Bio-tech Co., Ltd.JS

Conditions

Influenza Vaccine

Phase 4

Preliminary Safety Assessment of a Quadrivalent Subunit Influenza Vaccine in China

CompletedNCT07710586

Ab&B Bio-tech Co., Ltd.JSInfluenza Vaccine

Start: 2024-11-15End: 2025-05-29Updated: 2026-07-20

Unknown Phase

Safety Study of Quadrivalent Subunit Influenza Vaccine in People Aged 3 Years and Older

CompletedNCT07332689

Ab&B Bio-tech Co., Ltd.JSInfluenza Vaccine

Start: 2023-10-30End: 2025-04-28Updated: 2026-01-12

Related Papers

Post-Marketing Active Surveillance of Adverse Events Following Quadrivalent Subunit Influenza Vaccine in Healthy Participants Aged ≥ 3 Years in China

Infectious Diseases and Therapy2026-05-08